IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Healthcare Value Capital, LLC

Q1 2019 Holdings

Filed 2019-05-14 | 10 holdings | $26.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Allergan PLCSHSG0177J108$4.4K30,00016.9%
Glaxosmithkline PLCSPONSORED ADR37733W105$4.2K100,00016.1%
Tyme Technologies IncCOM90238J103$3.8K2,175,00014.7%
Gilead Sciences Inc(GILD)COM375558103$3.3K50,00012.5%
Ligand Pharmaceuticals Inc(LGND)PutCOM NEW53220K504$3.1K25,00012.1%
Viking Therapeutics Inc(VKTX)COM92686J106$2.5K250,0009.6%
Novelion Therapeutics IncCOM NEW67001K202$2.2K1,800,0008.5%
Viking Therapeutics Inc(VKTX)CallCOM92686J106$994100,0003.8%
Antares Pharma Inc(ATRSEUR)COM036642106$758250,0002.9%
Adamas Pharmaceuticals Inc(ADMSEUR)COM00548A106$711100,0002.7%